PMCF Investigation of Medical Device ChitoCare® Medical

Launched by PRIMEX EHF · Feb 24, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a medical device called ChitoCare® Medical, which comes in two forms: a gel and a spray. The trial aims to confirm how safe and effective these products are for treating conditions like scars, acne, dermatitis (a skin irritation), and issues that can occur after skin procedures. The trial is part of a follow-up to ensure that the device meets European safety standards.

Anyone who has scars, acne, dermatitis, or has recently undergone a skin procedure might be eligible to participate, as long as they are not allergic to any of the ingredients in ChitoCare® Medical. The trial is not actively recruiting participants yet, but once it starts, participants can expect to use either the gel or spray as part of the study. This is an important step in understanding how well these products work for different skin conditions and ensuring they are safe for everyone.

Gender

ALL

Eligibility criteria

• The inclusion criteria are fully according to indications:
• • Gel - scars, conditions after dermatosurgical procedures, dermatitis, acne
• • Spray - conditions after dermatosurgical procedures, dermatitis, acne
• The criteria for exclusion are fully according to contraindications:
• • Allergy to any of the ingredients of the product